ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 628,70
0,22%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) Actualités

HRTX

Heron Therapeautics (HRTX)

Heron Therapeautics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HRTX
DateHeureSourceTitreSymboleSociété
31/05/202417h08Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
29/05/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRTXHeron Therapeautics Inc
29/05/202414h05PR Newswire (US)Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")NASDAQ:HRTXHeron Therapeautics Inc
07/05/202414h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HRTXHeron Therapeautics Inc
07/05/202414h00PR Newswire (US)Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
24/04/202414h00PR Newswire (US)Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NASDAQ:HRTXHeron Therapeautics Inc
11/04/202422h05PR Newswire (US)Heron Therapeutics to Host Investor Day on May 15, 2024 in New York CityNASDAQ:HRTXHeron Therapeautics Inc
28/03/202421h05PR Newswire (US)Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:HRTXHeron Therapeautics Inc
13/03/202421h25AllPennyStocks.comBiotech Finds Mid-Week Success Following Q4 Earnings ReleaseNASDAQ:HRTXHeron Therapeautics Inc
12/03/202421h05PR Newswire (US)Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
12/03/202412h22IH Market NewsGlobal Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market TradingNASDAQ:HRTXHeron Therapeautics Inc
28/02/202414h00PR Newswire (US)Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024NASDAQ:HRTXHeron Therapeautics Inc
14/02/202422h37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRTXHeron Therapeautics Inc
24/01/202415h25AllPennyStocks.comPremarket Heats Up For Biotech Before Opening BellNASDAQ:HRTXHeron Therapeautics Inc
24/01/202402h00PR Newswire (US)Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue ProceduresNASDAQ:HRTXHeron Therapeautics Inc
20/01/202403h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
07/01/202423h00PR Newswire (US)Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative PainNASDAQ:HRTXHeron Therapeautics Inc
15/11/202318h25AllPennyStocks.comBiotech Shares Up Sharply Following Quarterly ResultsNASDAQ:HRTXHeron Therapeautics Inc
14/11/202322h05PR Newswire (US)Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial GuidanceNASDAQ:HRTXHeron Therapeautics Inc
07/11/202322h05PR Newswire (US)Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023NASDAQ:HRTXHeron Therapeautics Inc
23/08/202322h08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:HRTXHeron Therapeautics Inc
14/08/202322h05PR Newswire (US)Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:HRTXHeron Therapeautics Inc
07/08/202322h05PR Newswire (US)Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023NASDAQ:HRTXHeron Therapeautics Inc
01/08/202319h56Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:HRTXHeron Therapeautics Inc
25/07/202322h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HRTXHeron Therapeautics Inc
24/07/202315h02PR Newswire (US)Heron Therapeutics Announces Cost Reduction Plan and RestructuringNASDAQ:HRTXHeron Therapeautics Inc
24/07/202315h00PR Newswire (US)Heron Therapeutics Announces $30 Million Private Placement FinancingNASDAQ:HRTXHeron Therapeautics Inc
30/06/202322h06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HRTXHeron Therapeautics Inc
23/06/202322h29Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HRTXHeron Therapeautics Inc
23/06/202322h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HRTXHeron Therapeautics Inc
 Showing the most relevant articles for your search:NASDAQ:HRTX

Dernières Valeurs Consultées

BIT
P1RII1
BNP Paribas Issuance
LSE
AMI
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés